Cite
HARVARD Citation
Vaglica, M. et al. (n.d.). 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab. European journal of cancer. pp. S286-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vaglica, M. et al. (n.d.). 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab. European journal of cancer. pp. S286-. [Online].